WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark TIVDAQ was filed as Word mark on 10/25/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1627871 |
| Countries | 
|
| Base trademark |
No. 90675409,
April 27, 2021
|
| Application date | October 25, 2021 |
| Expiration date | October 25, 2031 |
Trademark owner
21823 30th Drive S.E.
Bothell WA 98021
US
Bothell WA 98021
US
Trademark representatives
379 Lytton Avenue
Palo Alto CA 94301
US
goods and services
05
Pharmaceutical preparations for use in humans, namely,
chemotherapeutics and biopharmaceuticals for the treatment
of diseases and conditions; pharmaceutical preparations for
the prevention and treatment of disorders of the nervous
system, the immune system, the cardio-vascular system, the
metabolic system, the respiratory system, the
musculo-skeletal system, and the genitourinary system;
pharmaceutical preparations for the treatment of cancer,
autoimmune diseases, and inflammatory disorders;
pharmaceutical preparations for use in dermatology,
oncology, hematology, ophthalmology, gastroenterological
disorders, and tissue and organ transplantology
42
Biotechnology research, namely, research and development of
pharmaceutical preparations for use in humans; research and
development of pharmaceutical preparations for the
diagnosis, prevention and treatment of disorders of the
nervous system, the immune system, the cardio-vascular
system, the metabolic system, the respiratory system, the
musculo-skeletal system, and the genitourinary system;
research and development of pharmaceutical preparations for
the diagnosis, prevention and treatment of cancer,
autoimmune diseases, inflammatory disorders,
gastroenterological disorders and for use in dermatology,
oncology, hematology, ophthalmology, and tissue and organ
transplantation
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 18, 2023 | 2023/16 Gaz | KR | Rejection |
| April 5, 2023 | 2023/14 Gaz | BR | Rejection |
| March 10, 2023 | 2023/11 Gaz | CA | Rejection |
| December 1, 2022 | 2022/48 Gaz | NO | Rejection |
| November 3, 2022 | 2022/48 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 20, 2022 | 2022/42 Gaz | CH | Rejection |
| October 17, 2022 | 2022/42 Gaz | IN | Rejection |
| September 26, 2022 | 2022/39 Gaz | MX | Rejection |
| June 28, 2022 | 2022/26 Gaz | NZ | Rejection |
| May 21, 2022 | 2022/21 Gaz | SG | Rejection |
| May 17, 2022 | 2022/20 Gaz | TR | Rejection |
| April 13, 2022 | 2022/15 Gaz | EM | Rejection |
| April 6, 2022 | 2022/16 Gaz | IL | Rejection |
| March 14, 2022 | 2022/11 Gaz | CN | Rejection |
| March 3, 2022 | 2022/9 Gaz | GB | Rejection |
| February 14, 2022 | 2022/7 Gaz | RU | Rejection |
| February 9, 2022 | 2022/6 Gaz | AU | Rejection |
| October 25, 2021 | 2021/45 Gaz | US | Registration |
ID: 141627871